Feasibility of and associated cost savings from transitioning to therapeutic biosimilar use in a large community oncology network.

9Background: The use of biosimilar drugs in the treatment of cancer offer an opportunity for oncology providers to decrease total cost of care while preserving quality. However, it remains unclear ...